Skip to main content
. 2019 Nov 13;52(6):416–426. doi: 10.3961/jpmph.19.180

Table 2.

Associations of variables related to demographics, lifestyle, clinical conditions, and climate with respiratory symptoms

Variables Symptom 1 Symptom 2 Symptom 3 Symptom 4 Symptom 5
Living in Yamaguchi area (vs. Niigata area) 0.788 (0.609, 1.020) 1.037 (0.850, 1.264) 1.095 (0.884, 1.356) 1.078 (0.864, 1.345) 1.433 (1.138, 1.804)**
Age (10-y increments) 0.912 (0.791, 1.051) 0.968 (0.860, 1.088) 1.087 (0.955, 1.237) 1.115 (0.972, 1.279) 0.712 (0.620, 0.818)***
Male (vs. female) 0.784 (0.605, 1.014) 1.304 (1.068, 1.591)** 1.277 (1.023, 1.595)* 0.969 (0.761, 1.235) 0.674 (0.540, 0.841)***
Body mass index (1 kg/m2 increments) 0.980 (0.954, 1.008) 1.007 (0.984, 1.031) 1.025 (0.999, 1.051) 1.024 (0.998, 1.051) 0.996 (0.971, 1.022)
Smoking status (vs. never smoker)
 Current smoker 0.980 (0.692, 1.387) 2.110 (1.659, 2.683)*** 2.570 (1.966, 3.360)*** 2.311 (1.706, 3.130)*** 0.640 (0.476, 0.863)**
 Ex-smoker 0.870 (0.668, 1.134) 1.064 (0.872, 1.299) 1.057 (0.841, 1.329) 1.126 (0.875, 1.448) 0.879 (0.695, 1.113)
Hay fever (vs. without hay fever) 2.486 (2.030, 3.044)*** 1.246 (1.051, 1.477)* 1.351 (1.128, 1.618)** 1.764 (1.449, 2.148)*** 7.211 (6.047, 8.599)***
COPD stage (vs. without COPD)
 GOLD stage 3 or 4 8.771 (5.604, 13.727)*** 5.333 (3.644, 7.805)*** 5.178 (3.572, 7.506)*** 13.444 (9.272, 19.494)*** 1.137 (0.719, 1.799)
 GOLD stage 2 6.256 (4.063, 9.633)*** 4.867 (3.388, 6.991)*** 3.168 (2.179, 4.605)*** 7.452 (5.171, 10.739)*** 1.078 (0.664, 1.750)
 GOLD stage 1 3.712 (2.282, 6.041)*** 2.859 (1.962, 4.167)*** 2.253 (1.532, 3.314)*** 3.863 (2.497, 5.977)*** 1.470 (0.894, 2.418)
Bronchial asthma (vs. without asthma) 7.853 (5.777, 10.675)*** 4.426 (3.489, 5.615)*** 4.214 (3.258, 5.450)*** 8.710 (6.668, 11.379)*** 3.740 (2.885, 4.847)***
Interaction (COPD*Asthma) 0.135 (0.087, 0.211)*** 0.293 (0.199, 0.431)*** 0.317 (0.215, 0.468)*** 0.135 (0.091, 0.198)*** 0.477 (0.297, 0.764)**
Time spent outdoors (1-hr increments) 0.977 (0.950, 1.005) 0.997 (0.978, 1.016) 1.001 (0.980, 1.023) 1.012 (0.987, 1.037) 0.963 (0.941, 0.985)**
Temperature (10°C increments) 1.026 (0.930, 1.132) 0.986 (0.925, 1.051) 1.044 (0.969, 1.125) 0.985 (0.902, 1.076) 0.999 (0.922, 1.082)
Relative humidity (10% increments) 0.998 (0.903, 1.102) 1.122 (1.040, 1.210)** 1.084 (0.999, 1.175) 0.903 (0.828, 0.985)* 0.859 (0.783, 0.944)**
Oxidants (10 ppb increments) 1.094 (1.022, 1.171)** 1.139 (1.083, 1.198)*** 1.096 (1.038, 1.157)** 1.022 (0.961, 1.087) 1.057 (0.993, 1.125)
SPM (10 µg/m3 increments) 1.005 (0.915, 1.104) 1.030 (0.955, 1.112) 1.013 (0.935, 1.097) 0.951 (0.874, 1.035) 1.095 (0.952, 1.260)
PM2.5 (10 µg/m3 increments) 1.105 (0.921, 1.325) 1.107 (0.960, 1.278) 1.125 (0.964, 1.313) 0.935 (0.800, 1.093) 1.098 (0.929, 1.299)
ASD event (experienced) 1.071 (0.864, 1.327) 1.059 (0.889, 1.261) 1.150 (0.963, 1.374) 1.118 (0.917, 1.363) 1.270 (1.041, 1.549)*

Values are presented as odds ratio (95% confidence interval).

Odds ratios were adjusted by region of the survey, sex, age, body mass index (kg/m2), smoking status (current, ex- or never-smoker), COPD severity (GOLD stage 3 and 4, 2, 1 or 0), physician-diagnosed asthma, interaction between COPD and asthma, time spent outdoors (h), ambient temperature (°C), and relative humidity (%).

Symptom 1, weather affects a cough (negative=0; positive=1); Symptom 2, coughing up sputum when the subject does not have a cold (negative=0; positive=1); Symptom 3, coughing up sputum first thing in the morning (negative=0; positive=1); Symptom 4, frequent wheezing (negative=0; positive=1); Symptom 5, allergic symptoms (negative=0; positive=1); COPD, chronic obstructive pulmonary disease; GOLD, Global Initiative for Chronic Obstructive Lung Disease; SPM, suspended particulate matter; PM2.5, particulate matter <2.5 μm in diameter; ASD, Asian sand dust.

*

p<0.05,

**

p<0.01,

***

p<0.001.